Skip to Main Content

Paper Details

WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects.
Molecular Therapy
2
2023
SHN3, SOST, WNT, allograft, artificial microRNAs, bone fracture, bone fractures, bone-specific gene silencers, critical-sized bone defects, fracture, low bone mass, miRNAs, osteoblast, osteoporosis, osteotomy sites, postmenopausal and senile osteoporosis, schnurri-3, sclerostin, skeletal disorders
Author NameAffiliation
Jun XieUniversity of Massachusetts Chan Medical School
Guangping GaoUniversity of Massachusetts Chan Medical School, USA Li Weibo Institute for Rare Diseases Research
  • 1 - 2

Datasets

Release 1.2